You have 9 free searches left this month | for more free features.

City

Bethesda (1)

Stanford (1)

Overall Status

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1/phase 2 (2)

Sponsor

National Cancer Institute (NCI) (1)

Sandy Srinivas (1)

Collaborator

American Society of Clinical Oncology (1)

National Comprehensive Cancer Network (1)

Wyeth is now a wholly owned subsidiary of Pfizer (1)

Intervention

berzosertib (1)

casodex (bicalutamide) (1)

lurbinectedin (1)

temsirolimus (1)

Study Documents

Intervention Type

drug (2)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

HGNC

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)

Recruiting

SCLC
+3 more

Bethesda, Maryland

National Institutes of Health Clinical Center

Jan 20, 2023

Prostate Cancer, Prostatic Tumors, Castrate-resistant Prostate Cancer (CRPC) Trial in Stanford (Temsirolimus, Casodex

Terminated

Has Results

Prostate Cancer
+5 more

Temsirolimus
Casodex (bicalutamide)

Stanford, California

Stanford University School of Medicine

Oct 3, 2014